Dave Olsen / via Flickr

PAETEC settles down

Telecommunications firm, PAETEC has reached an agreement with the City of Rochester to locate its corporate headquarters downtown. The Rochester Business Journal summarized the major investments pledged by both parties to make a deal:

US Army / via Flickr

Buffalo-based drug maker Cleveland Biolabs has been working on a medicine to protect against radiation poisoning for more than seven years. And this week the drug, CBLB502, took another step towards approval by the Food and Drug Administration.

Oliver / via Flickr

While Cleveland Biolabs (headquartered in Buffalo) continues seeking approval of its anti-radiation drug CBLB502 from the Food and Drug Administration, the pharmaceutical company is beginning to seek markets and protection of its ideas in other countries.

Jesús Joglar / via Flickr

Last month I reported a story about the development of an anti-radiation drug from Cleveland Biolabs (based in Buffalo). The medicine is being eyed as a way to treat victims of a nuclear attack. There are no existing medicines that actually clear radiation out of your blood stream if you’ve been exposed – only ways to reduce exposure.